We congratulate the research team of Thomas Papathomas, Steve Silverstein and Attila Farkas, who have been awarded two grants to develop and test a patent-pending portable device as a diagnostic and evaluating tool for schizophrenia (SZ). The grants are funded by TechAdvance and the New Jersey Health Foundation (NJHF). They will support the final stages of developing a stand-alone application for a smartphone that will enable testing of SZ patients in their own environment, as well as experiments to test inpatients upon hospital admission.
In The News
Papathomas, Silverstein and Farkas Team Awarded Grants by TechAdvance and NJHF
- Details